Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 12 of 271 entries
Sorted by: Best Match Show Resources per page
Silver-Catalyzed 1,3-Acyloxy Migration/Diels-Alder Reaction of 1,9-Dien-4-yne Esters to Partially Hydrogenated Isoquinolines.

The Journal of organic chemistry

Zhao Y, Jin J, Boyle JW, Lee BR, Day DP, Susanti D, Clarkson GJ, Chan PW.
PMID: 28225621
J Org Chem. 2017 Mar 17;82(6):2826-2834. doi: 10.1021/acs.joc.7b00048. Epub 2017 Mar 07.

A synthetic method to prepare partially hydrogenated isoquinolines efficiently from silver-mediated [3,3]-sigmatropic rearrangement/Diels-Alder reaction of 1,9-dien-4-yne esters is described. The reactions were shown to be robust with a wide variety of substitution patterns tolerated to provide the corresponding nitrogen-containing...

Cite
Zhao Y, Jin J, Boyle JW, et al. Silver-Catalyzed 1,3-Acyloxy Migration/Diels-Alder Reaction of 1,9-Dien-4-yne Esters to Partially Hydrogenated Isoquinolines. J Org Chem. 2017;82(6):2826-2834doi: 10.1021/acs.joc.7b00048.
Zhao, Y., Jin, J., Boyle, J. W., Lee, B. R., Day, D. P., Susanti, D., Clarkson, G. J., & Chan, P. W. (2017). Silver-Catalyzed 1,3-Acyloxy Migration/Diels-Alder Reaction of 1,9-Dien-4-yne Esters to Partially Hydrogenated Isoquinolines. The Journal of organic chemistry, 82(6), 2826-2834. https://doi.org/10.1021/acs.joc.7b00048
Zhao, Yichao, et al. "Silver-Catalyzed 1,3-Acyloxy Migration/Diels-Alder Reaction of 1,9-Dien-4-yne Esters to Partially Hydrogenated Isoquinolines." The Journal of organic chemistry vol. 82,6 (2017): 2826-2834. doi: https://doi.org/10.1021/acs.joc.7b00048
Zhao Y, Jin J, Boyle JW, Lee BR, Day DP, Susanti D, Clarkson GJ, Chan PW. Silver-Catalyzed 1,3-Acyloxy Migration/Diels-Alder Reaction of 1,9-Dien-4-yne Esters to Partially Hydrogenated Isoquinolines. J Org Chem. 2017 Mar 17;82(6):2826-2834. doi: 10.1021/acs.joc.7b00048. Epub 2017 Mar 07. PMID: 28225621.
Copy Download .nbib Format: NLM
Xenograft models for undifferentiated pleomorphic sarcoma not otherwise specified are essential for preclinical testing of therapeutic agents.

Oncology letters

Becker M, Graf C, Tonak M, Radsak MP, Bopp T, Bals R, Bohle RM, Theobald M, Rommens PM, Proschek D, Wehler TC.
PMID: 27446424
Oncol Lett. 2016 Aug;12(2):1257-1264. doi: 10.3892/ol.2016.4784. Epub 2016 Jun 24.

Undifferentiated pleomorphic sarcoma not otherwise specified belongs to the heterogeneous group of soft tissue tumors. It is preferentially located in the upper and lower extremities of the body, and surgical resection remains the only curative treatment. Preclinical animal models...

Cite
Becker M, Graf C, Tonak M, et al. Xenograft models for undifferentiated pleomorphic sarcoma not otherwise specified are essential for preclinical testing of therapeutic agents. Oncol Lett. 2016;12(2):1257-1264doi: 10.3892/ol.2016.4784.
Becker, M., Graf, C., Tonak, M., Radsak, M. P., Bopp, T., Bals, R., Bohle, R. M., Theobald, M., Rommens, P. M., Proschek, D., & Wehler, T. C. (2016). Xenograft models for undifferentiated pleomorphic sarcoma not otherwise specified are essential for preclinical testing of therapeutic agents. Oncology letters, 12(2), 1257-1264. https://doi.org/10.3892/ol.2016.4784
Becker, Marc, et al. "Xenograft models for undifferentiated pleomorphic sarcoma not otherwise specified are essential for preclinical testing of therapeutic agents." Oncology letters vol. 12,2 (2016): 1257-1264. doi: https://doi.org/10.3892/ol.2016.4784
Becker M, Graf C, Tonak M, Radsak MP, Bopp T, Bals R, Bohle RM, Theobald M, Rommens PM, Proschek D, Wehler TC. Xenograft models for undifferentiated pleomorphic sarcoma not otherwise specified are essential for preclinical testing of therapeutic agents. Oncol Lett. 2016 Aug;12(2):1257-1264. doi: 10.3892/ol.2016.4784. Epub 2016 Jun 24. PMID: 27446424; PMCID: PMC4950181.
Copy Download .nbib Format: NLM
Generation of Triplet Excited States via Photoinduced Electron Transfer in meso-anthra-BODIPY: Fluorogenic Response toward Singlet Oxygen in Solution and in Vitro.

Journal of the American Chemical Society

Filatov MA, Karuthedath S, Polestshuk PM, Savoie H, Flanagan KJ, Sy C, Sitte E, Telitchko M, Laquai F, Boyle RW, Senge MO.
PMID: 28407710
J Am Chem Soc. 2017 May 10;139(18):6282-6285. doi: 10.1021/jacs.7b00551. Epub 2017 May 01.

Heavy atom-free BODIPY-anthracene dyads (BADs) generate locally excited triplet states by way of photoinduced electron transfer (PeT), followed by recombination of the resulting charge-separated states (CSS). Subsequent quenching of the triplet states by molecular oxygen produces singlet oxygen (

Cite
Filatov MA, Karuthedath S, Polestshuk PM, et al. Generation of Triplet Excited States via Photoinduced Electron Transfer in meso-anthra-BODIPY: Fluorogenic Response toward Singlet Oxygen in Solution and in Vitro. J Am Chem Soc. 2017;139(18):6282-6285doi: 10.1021/jacs.7b00551.
Filatov, M. A., Karuthedath, S., Polestshuk, P. M., Savoie, H., Flanagan, K. J., Sy, C., Sitte, E., Telitchko, M., Laquai, F., Boyle, R. W., & Senge, M. O. (2017). Generation of Triplet Excited States via Photoinduced Electron Transfer in meso-anthra-BODIPY: Fluorogenic Response toward Singlet Oxygen in Solution and in Vitro. Journal of the American Chemical Society, 139(18), 6282-6285. https://doi.org/10.1021/jacs.7b00551
Filatov, Mikhail A, et al. "Generation of Triplet Excited States via Photoinduced Electron Transfer in meso-anthra-BODIPY: Fluorogenic Response toward Singlet Oxygen in Solution and in Vitro." Journal of the American Chemical Society vol. 139,18 (2017): 6282-6285. doi: https://doi.org/10.1021/jacs.7b00551
Filatov MA, Karuthedath S, Polestshuk PM, Savoie H, Flanagan KJ, Sy C, Sitte E, Telitchko M, Laquai F, Boyle RW, Senge MO. Generation of Triplet Excited States via Photoinduced Electron Transfer in meso-anthra-BODIPY: Fluorogenic Response toward Singlet Oxygen in Solution and in Vitro. J Am Chem Soc. 2017 May 10;139(18):6282-6285. doi: 10.1021/jacs.7b00551. Epub 2017 May 01. PMID: 28407710.
Copy Download .nbib Format: NLM
Psychiatric symptoms in glioma patients: from diagnosis to management.

Neuropsychiatric disease and treatment

Boele FW, Rooney AG, Grant R, Klein M.
PMID: 26089669
Neuropsychiatr Dis Treat. 2015 Jun 10;11:1413-20. doi: 10.2147/NDT.S65874. eCollection 2015.

Patients with primary intrinsic brain tumors can experience neurological, cognitive, and psychiatric symptoms that greatly affect daily life. In this review, we focus on changes in personality and behavior, mood issues, hallucinations, and psychosis, because these are either difficult...

Cite
Boele FW, Rooney AG, Grant R, et al. Psychiatric symptoms in glioma patients: from diagnosis to management. Neuropsychiatr Dis Treat. 2015;11:1413-20doi: 10.2147/NDT.S65874.
Boele, F. W., Rooney, A. G., Grant, R., & Klein, M. (2015). Psychiatric symptoms in glioma patients: from diagnosis to management. Neuropsychiatric disease and treatment, 111413-20. https://doi.org/10.2147/NDT.S65874
Boele, Florien W, et al. "Psychiatric symptoms in glioma patients: from diagnosis to management." Neuropsychiatric disease and treatment vol. 11 (2015): 1413-20. doi: https://doi.org/10.2147/NDT.S65874
Boele FW, Rooney AG, Grant R, Klein M. Psychiatric symptoms in glioma patients: from diagnosis to management. Neuropsychiatr Dis Treat. 2015 Jun 10;11:1413-20. doi: 10.2147/NDT.S65874. eCollection 2015. PMID: 26089669; PMCID: PMC4467748.
Copy Download .nbib Format: NLM
Correction to "assessing the dual activity of a chalcone-phthalocyanine conjugate: design, synthesis, and antivascular and photodynamic properties".

Molecular pharmaceutics

Tuncel S, Trivella A, Atilla D, Bennis K, Savoie H, Albrieux F, Delort L, Billard H, Dubois V, Ahsen V, Caldefie-Chézet F, Richard C, Boyle RW, Ducki S, Dumoulin F.
PMID: 25590168
Mol Pharm. 2015 Feb 02;12(2):663. doi: 10.1021/mp5008426. Epub 2015 Jan 15.

No abstract available.

Cite
Tuncel S, Trivella A, Atilla D, et al. Correction to "assessing the dual activity of a chalcone-phthalocyanine conjugate: design, synthesis, and antivascular and photodynamic properties". Mol Pharm. 2015;12(2):663doi: 10.1021/mp5008426.
Tuncel, S., Trivella, A., Atilla, D., Bennis, K., Savoie, H., Albrieux, F., Delort, L., Billard, H., Dubois, V., Ahsen, V., Caldefie-Chézet, F., Richard, C., Boyle, R. W., Ducki, S., & Dumoulin, F. (2015). Correction to "assessing the dual activity of a chalcone-phthalocyanine conjugate: design, synthesis, and antivascular and photodynamic properties". Molecular pharmaceutics, 12(2), 663. https://doi.org/10.1021/mp5008426
Tuncel, Sinem, et al. "Correction to "assessing the dual activity of a chalcone-phthalocyanine conjugate: design, synthesis, and antivascular and photodynamic properties"." Molecular pharmaceutics vol. 12,2 (2015): 663. doi: https://doi.org/10.1021/mp5008426
Tuncel S, Trivella A, Atilla D, Bennis K, Savoie H, Albrieux F, Delort L, Billard H, Dubois V, Ahsen V, Caldefie-Chézet F, Richard C, Boyle RW, Ducki S, Dumoulin F. Correction to "assessing the dual activity of a chalcone-phthalocyanine conjugate: design, synthesis, and antivascular and photodynamic properties". Mol Pharm. 2015 Feb 02;12(2):663. doi: 10.1021/mp5008426. Epub 2015 Jan 15. PMID: 25590168.
Copy Download .nbib Format: NLM
Deficits in quantity and quality.

Nursing outlook

Boyle R.
PMID: 5177049
Nurs Outlook. 1966 May;14(5):29.

No abstract available.

Cite
Boyle R. Deficits in quantity and quality. Nurs Outlook. 1966;14(5):29
Boyle, R. (1966). Deficits in quantity and quality. Nursing outlook, 14(5), 29.
Boyle, R. "Deficits in quantity and quality." Nursing outlook vol. 14,5 (1966): 29.
Boyle R. Deficits in quantity and quality. Nurs Outlook. 1966 May;14(5):29. PMID: 5177049.
Copy Download .nbib Format: NLM
First synthesis of porphyrin-phthalocyanine heterodimers with a direct ethynyl linkage.

Chemical communications (Cambridge, England)

Sutton JM, Boyle RW.
PMID: 12240266
Chem Commun (Camb). 2001 Oct 07;(19):2014-5. doi: 10.1039/b105840c.

The first synthesis of two porphyrin-phthalocyanine heterodimers with a direct triple bond linkage between the macrocycles, designed for the study of photo-induced energy and electron transfer processes, is presented along with preliminary ground state and fluorescence spectroscopic data.

Cite
Sutton JM, Boyle RW. First synthesis of porphyrin-phthalocyanine heterodimers with a direct ethynyl linkage. Chem Commun (Camb). 2001;(19):2014-5doi: 10.1039/b105840c.
Sutton, J. M., & Boyle, R. W. (2001). First synthesis of porphyrin-phthalocyanine heterodimers with a direct ethynyl linkage. Chemical communications (Cambridge, England), (19), 2014-5. https://doi.org/10.1039/b105840c
Sutton, J M, and Boyle, R W. "First synthesis of porphyrin-phthalocyanine heterodimers with a direct ethynyl linkage." Chemical communications (Cambridge, England) vol. ,19 (2001): 2014-5. doi: https://doi.org/10.1039/b105840c
Sutton JM, Boyle RW. First synthesis of porphyrin-phthalocyanine heterodimers with a direct ethynyl linkage. Chem Commun (Camb). 2001 Oct 07;(19):2014-5. doi: 10.1039/b105840c. PMID: 12240266.
Copy Download .nbib Format: NLM
CC-1065 and the Duocarmycins: Synthetic Studies.

Chemical reviews

Boger DL, Boyce CW, Garbaccio RM, Goldberg JA.
PMID: 11848889
Chem Rev. 1997 May 08;97(3):787-828. doi: 10.1021/cr960095g.

No abstract available.

Cite
Boger DL, Boyce CW, Garbaccio RM, et al. CC-1065 and the Duocarmycins: Synthetic Studies. Chem Rev. 1997;97(3):787-828doi: 10.1021/cr960095g.
Boger, D. L., Boyce, C. W., Garbaccio, R. M., & Goldberg, J. A. (1997). CC-1065 and the Duocarmycins: Synthetic Studies. Chemical reviews, 97(3), 787-828. https://doi.org/10.1021/cr960095g
Boger, Dale L., et al. "CC-1065 and the Duocarmycins: Synthetic Studies." Chemical reviews vol. 97,3 (1997): 787-828. doi: https://doi.org/10.1021/cr960095g
Boger DL, Boyce CW, Garbaccio RM, Goldberg JA. CC-1065 and the Duocarmycins: Synthetic Studies. Chem Rev. 1997 May 08;97(3):787-828. doi: 10.1021/cr960095g. PMID: 11848889.
Copy Download .nbib Format: NLM
A conversion code from ICHPPC-1 to ICHPPC-2.

The Journal of family practice

Becker LA, Boyle RM, Froom J, Schneeweiss R, Wood M.
PMID: 7205173
J Fam Pract. 1981 Apr;12(4):707-19.

Faculty members from four departments of family medicine participated in the production of a definitive conversion from the first to the second versions of the International Classification of Health Problems in Primary Care (ICHPPC). A detailed conversion code with...

Cite
Becker LA, Boyle RM, Froom J, et al. A conversion code from ICHPPC-1 to ICHPPC-2. J Fam Pract. 1981;12(4):707-19
Becker, L. A., Boyle, R. M., Froom, J., Schneeweiss, R., & Wood, M. (1981). A conversion code from ICHPPC-1 to ICHPPC-2. The Journal of family practice, 12(4), 707-19.
Becker, L A, et al. "A conversion code from ICHPPC-1 to ICHPPC-2." The Journal of family practice vol. 12,4 (1981): 707-19.
Becker LA, Boyle RM, Froom J, Schneeweiss R, Wood M. A conversion code from ICHPPC-1 to ICHPPC-2. J Fam Pract. 1981 Apr;12(4):707-19. PMID: 7205173.
Copy Download .nbib Format: NLM
Photodynamic therapy and the development of metal-based photosensitisers.

Metal-based drugs

Josefsen LB, Boyle RW.
PMID: 18815617
Met Based Drugs. 2008;2008:276109. doi: 10.1155/2008/276109.

Photodynamic therapy (PDT) is a treatment modality that has been used in the successful treatment of a number of diseases and disorders, including age-related macular degeneration (AMD), psoriasis, and certain cancers. PDT uses a combination of a selectively localised...

Cite
Josefsen LB, Boyle RW. Photodynamic therapy and the development of metal-based photosensitisers. Met Based Drugs. 2008;2008:276109doi: 10.1155/2008/276109.
Josefsen, L. B., & Boyle, R. W. (2008). Photodynamic therapy and the development of metal-based photosensitisers. Metal-based drugs, 2008276109. https://doi.org/10.1155/2008/276109
Josefsen, Leanne B, and Boyle, Ross W. "Photodynamic therapy and the development of metal-based photosensitisers." Metal-based drugs vol. 2008 (2008): 276109. doi: https://doi.org/10.1155/2008/276109
Josefsen LB, Boyle RW. Photodynamic therapy and the development of metal-based photosensitisers. Met Based Drugs. 2008;2008:276109. doi: 10.1155/2008/276109. PMID: 18815617; PMCID: PMC2535827.
Copy Download .nbib Format: NLM
The relationship between prevalence and duration of weight loss strategies and weight loss among overweight managed care organization members enrolled in a weight loss trial.

The international journal of behavioral nutrition and physical activity

Linde JA, Erickson DJ, Jeffery RW, Pronk NP, Boyle RG.
PMID: 16503980
Int J Behav Nutr Phys Act. 2006 Feb 17;3:3. doi: 10.1186/1479-5868-3-3.

BACKGROUND: Many adults in the United States report engaging in weight loss behaviors. The current study examined weight loss strategies among managed care organization members, to determine the prevalence and impact of weight loss behaviors in this population. We...

Cite
Linde JA, Erickson DJ, Jeffery RW, et al. The relationship between prevalence and duration of weight loss strategies and weight loss among overweight managed care organization members enrolled in a weight loss trial. Int J Behav Nutr Phys Act. 2006;3:3doi: 10.1186/1479-5868-3-3.
Linde, J. A., Erickson, D. J., Jeffery, R. W., Pronk, N. P., & Boyle, R. G. (2006). The relationship between prevalence and duration of weight loss strategies and weight loss among overweight managed care organization members enrolled in a weight loss trial. The international journal of behavioral nutrition and physical activity, 33. https://doi.org/10.1186/1479-5868-3-3
Linde, Jennifer A, et al. "The relationship between prevalence and duration of weight loss strategies and weight loss among overweight managed care organization members enrolled in a weight loss trial." The international journal of behavioral nutrition and physical activity vol. 3 (2006): 3. doi: https://doi.org/10.1186/1479-5868-3-3
Linde JA, Erickson DJ, Jeffery RW, Pronk NP, Boyle RG. The relationship between prevalence and duration of weight loss strategies and weight loss among overweight managed care organization members enrolled in a weight loss trial. Int J Behav Nutr Phys Act. 2006 Feb 17;3:3. doi: 10.1186/1479-5868-3-3. PMID: 16503980; PMCID: PMC1386697.
Copy Download .nbib Format: NLM
Lunar apatite with terrestrial volatile abundances.

Nature

Boyce JW, Liu Y, Rossman GR, Guan Y, Eiler JM, Stolper EM, Taylor LA.
PMID: 20651686
Nature. 2010 Jul 22;466(7305):466-9. doi: 10.1038/nature09274.

The Moon is thought to be depleted relative to the Earth in volatile elements such as H, Cl and the alkalis. Nevertheless, evidence for lunar explosive volcanism has been used to infer that some lunar magmas exsolved a CO-rich...

Cite
Boyce JW, Liu Y, Rossman GR, et al. Lunar apatite with terrestrial volatile abundances. Nature. 2010;466(7305):466-9doi: 10.1038/nature09274.
Boyce, J. W., Liu, Y., Rossman, G. R., Guan, Y., Eiler, J. M., Stolper, E. M., & Taylor, L. A. (2010). Lunar apatite with terrestrial volatile abundances. Nature, 466(7305), 466-9. https://doi.org/10.1038/nature09274
Boyce, Jeremy W, et al. "Lunar apatite with terrestrial volatile abundances." Nature vol. 466,7305 (2010): 466-9. doi: https://doi.org/10.1038/nature09274
Boyce JW, Liu Y, Rossman GR, Guan Y, Eiler JM, Stolper EM, Taylor LA. Lunar apatite with terrestrial volatile abundances. Nature. 2010 Jul 22;466(7305):466-9. doi: 10.1038/nature09274. PMID: 20651686.
Copy Download .nbib Format: NLM
Showing 1 to 12 of 271 entries